National survey of the in vitro spectrum of piperacillin-tazobactam tested against more than 40,000 aerobic clinical isolates from 236 medical centers.

National survey of the in vitro spectrum of piperacillin-tazobactam tested against more than 40,000 aerobic clinical isolates from 236 medical centers. by Baron EJ and Jones RN published in Diagn. Microbiol. Infect. Dis. 1995; 21 (3): 141-151